Hudson Value Partners LLC Has $732,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Hudson Value Partners LLC lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 35.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,446 shares of the healthcare conglomerate’s stock after purchasing an additional 377 shares during the period. Hudson Value Partners LLC’s holdings in UnitedHealth Group were worth $732,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in UNH. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group in the fourth quarter worth $30,000. RPg Family Wealth Advisory LLC acquired a new position in shares of UnitedHealth Group during the third quarter worth approximately $37,000. DecisionPoint Financial LLC increased its stake in UnitedHealth Group by 155.0% during the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after purchasing an additional 62 shares in the last quarter. Highline Wealth Partners LLC acquired a new position in shares of UnitedHealth Group during the third quarter valued at about $55,000. Finally, Legacy Investment Solutions LLC bought a new stake in UnitedHealth Group during the 3rd quarter worth approximately $57,000. 87.86% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research firms recently weighed in on UNH. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Barclays cut their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a research note on Friday, January 10th. Stephens raised their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Finally, Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. One research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $629.32.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Trading Down 4.2 %

NYSE UNH opened at $501.52 on Wednesday. The stock’s 50 day moving average is $521.08 and its 200 day moving average is $562.03. The firm has a market capitalization of $461.54 billion, a PE ratio of 32.36, a P/E/G ratio of 1.43 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period last year, the company earned $5.83 EPS. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.